Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.

By William E Boden, J. Probstfield, Todd Anderson, Bernard R. Chaitman, Patrice Desvignes-Nickens, K. Koprowicz, Ruth McBride, Koon K. Teo, William S Weintraub. New England Journal of Medicine, 2011

1,174 citations recorded by the source corpus.

Subfields: Cancer Research, Endocrinology, Diabetes and Metabolism, Surgery

View Paper: https://www.semanticscholar.org/paper/d76ac03611110eeffa5c3ad8b47d06f372d84eb6

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. Børge G. Nordestgaard
2. S. Grundy

In Endocrinology, Diabetes and Metabolism

1. Børge G. Nordestgaard
2. S. Grundy
3. Alberico L. Catapano
4. L. Tokgözoğlu
5. I. Graham

In Surgery

1. S. Grundy
2. Alberico L. Catapano
3. L. Tokgözoğlu
4. Børge G. Nordestgaard
5. I. Graham

Citations in the corpus

• Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement (2022, background): “Niacin is not recommended given the lack of clinical benefit in two outcomes studies.(200,201) Current data also do not support targeting aspirin use based on Lp(a) levels.”